[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Closing the Loop: Beyond Digital Detailing

November 2010 | 48 pages | ID: CD9432712FEEN
FirstWord

US$ 395.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Imagine this: Nearly all the puzzle pieces are in place. The picture is clear, but not yet finished. One part remains. But no matter how you try, something stops it from fitting it in place.

For the pharmaceutical industry, that last piece of the puzzle—Closed Loop Marketing (CLM)—can’t complete the picture without one final step. While industries everywhere have successfully adopted CLM to improve sales, adjust product to demand and develop marketing to suit consumers by ‘closing the loop’ or testing results, the pharmaceutical industry lags behind.

Yet there is no doubt that ‘closing the loop’ is just what the industry needs to do, as pharmaceutical marketing in mature and emerging markets alike becomes tougher, more regulated and therefore harder to penetrate. As many are turning to multiple channels, digital technology and digital detailing to get their message across, full implementation of CLM has yet to occur.

The question is why? There are many answers: insufficient digital experience in dealing with the mass of information gathered, lack of industry commitment to resources and incomplete vision of what—and where—CLM could go.

In Closing the Loop: Beyond Digital Detailing, FirstWord examines the current situation with CLM in the industry, and discovers just why the push towards using this innovative tool has stalled. Based on excellent research and extensive interviews with some of the most compelling voices in pharma marketing, the report details the industry’s stumbling blocks to successfully implementing CLM, offers a vision of how it can be used on a daily basis to improve sales, and suggests practical steps to achieving it. The report includes vital charts, metrics and a fascinating case study.

The report offers insights into:
  • Compelling interviews with leaders in pharma marketing
  • A vision for how CLM testing can lead to a more dynamic sales environment

Key features
  • A full breakdown of the five basic steps in implementing CLM
  • How CLM is used, including obstacles and a comparative analysis of US versus European experiences
  • A roadmap to full CLM implementation, from pilot to deployment
  • A review of data collection and analysis
  • Metrics to measure return on investment
  • A case study of Bayer’s CLM programme

Key quotes from the report

“CLM is not about devices. CLM is about relationship-building using data gleaned from customer interactions through various communication channels to support the continuous refining of relationships. The selection of the channel and the device to reach that channel should be driven by customer preference and/or customer receptivity.” Richie Bavasso, president of Exploria SPS

“People don’t know where to put CLM within a company. It is not IT, nor is not communications. It affects everything. CLM is about optimizing communications with target audiences be they doctors, patients or payers.” Christoph Ferse, Head of Global E-Excellence, Grunenthal
EXECUTIVE SUMMARY

THE STORY OF CLOSED-LOOP MARKETING

Declining access to doctors
Putting the customer at the centre

CLOSED-LOOP MARKETING: DEFINITION AND STEPS

What is CLM?
Five basic steps
CLM stakeholders

HOW CLM IS USED WITHIN THE INDUSTRY

Uptake slow but getting there
Uptake of CLM in US vs Europe
Structural obstacles to uptake
Operational obstacles

THE ROAD TO A CLM PROGRAMME

TEST IT AND SEE

FROM PILOT TO FULL DEPLOYMENT

Training the sales force
The importance of content
Multichannel marketing

DATA COLLECTION

DATA ANALYSIS

Analytical team

INSIGHT GENERATION

Customising the message
Closing the loop
Predictive modelling

METRICS TO MEASURE RETURN ON INVESTMENT

LEARNING FROM OTHER INDUSTRIES

CASE STUDY: BAYER GOES GLOBAL

LOOKING TO THE FUTURE

ACKNOWLEDGEMENTS

INDEX


More Publications